Bingjun Bai

582 total citations
26 papers, 424 citations indexed

About

Bingjun Bai is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Bingjun Bai has authored 26 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Bingjun Bai's work include Genetic factors in colorectal cancer (6 papers), Ferroptosis and cancer prognosis (4 papers) and Epigenetics and DNA Methylation (3 papers). Bingjun Bai is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Ferroptosis and cancer prognosis (4 papers) and Epigenetics and DNA Methylation (3 papers). Bingjun Bai collaborates with scholars based in China and Taiwan. Bingjun Bai's co-authors include Hongbo Zhu, Binbin Xie, Yiming Lv, Yuzi Xu, Engeng Chen, Xingxing Wang, Lina Shan, Hongming Pan, Xing Gao and Jinhui Hu and has published in prestigious journals such as Journal of Clinical Oncology, Signal Transduction and Targeted Therapy and BioMed Research International.

In The Last Decade

Bingjun Bai

24 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bingjun Bai China	12	182	153	108	75	56	26	424
Alice E. Shin United States	4	171 0.9×	158 1.0×	93 0.9×	70 0.9×	56 1.0×	6	374
Shangdan Xie China	11	258 1.4×	121 0.8×	163 1.5×	63 0.8×	53 0.9×	17	462
Hexiao Wang China	10	346 1.9×	139 0.9×	134 1.2×	56 0.7×	69 1.2×	18	538
Lucas Fass United States	3	208 1.1×	126 0.8×	95 0.9×	55 0.7×	100 1.8×	9	446
Lanya Li China	7	285 1.6×	132 0.9×	79 0.7×	45 0.6×	38 0.7×	12	433
Zhenqing Sun China	13	254 1.4×	109 0.7×	123 1.1×	60 0.8×	60 1.1×	22	445
Kailiang Zhao China	10	182 1.0×	117 0.8×	73 0.7×	54 0.7×	54 1.0×	38	354
Fatemeh Karimi Dermani Iran	7	247 1.4×	291 1.9×	132 1.2×	73 1.0×	145 2.6×	8	587
Shixin Xiang China	12	271 1.5×	217 1.4×	121 1.1×	92 1.2×	136 2.4×	17	540

Countries citing papers authored by Bingjun Bai

Since Specialization

Citations

This map shows the geographic impact of Bingjun Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjun Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjun Bai more than expected).

Fields of papers citing papers by Bingjun Bai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingjun Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjun Bai. The network helps show where Bingjun Bai may publish in the future.

Co-authorship network of co-authors of Bingjun Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Bingjun Bai. A scholar is included among the top collaborators of Bingjun Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingjun Bai. Bingjun Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, Zhangfa, et al.. (2025). Node-sparing modified short-course radiotherapy combined with CAPOX and tislelizumab versus conventional short-course preoperative chemoradiotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (mRCAT-III): A multicenter, randomized, open-label, phase 3 trial.. Journal of Clinical Oncology. 43(16_suppl).

Tong, Yifan, Mingyu Chen, Zhangfa Song, et al.. (2024). Safety of the stent-based diverting technique after low anterior resection in patients with rectal cancer. 2(3). 100079–100079.

Shan, Lina, et al.. (2024). Pyroptosis in cancer treatment and prevention: the role of natural products and their bioactive compounds. Medical Oncology. 41(3). 66–66. 6 indexed citations

Bai, Bingjun, et al.. (2024). Development of anti-cancer drugs for tumor-associated macrophages: a comprehensive review and mechanistic insights. Frontiers in Molecular Biosciences. 11. 1463061–1463061. 2 indexed citations

Lv, Yiming, et al.. (2023). A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response. Translational Cancer Research. 12(9). 2256–2275. 6 indexed citations

Chen, Yao, et al.. (2023). Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis. Diabetology & Metabolic Syndrome. 15(1). 252–252. 1 indexed citations

Chen, Yao, et al.. (2022). Anti-PD-1 combined with targeted therapy: Theory and practice in gastric and colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(5). 188775–188775. 23 indexed citations

Bai, Bingjun, Yuzi Xu, Yiming Lv, et al.. (2021). Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer. Theranostics. 11(13). 6225–6239. 54 indexed citations

Hu, Jinhui, et al.. (2021). Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer. Medical Oncology. 38(2). 21–21. 10 indexed citations

10.

Bai, Bingjun, et al.. (2021). Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer. Frontiers in Bioengineering and Biotechnology. 9. 670124–670124. 25 indexed citations

11.

Wang, Fei, Huanqing Cheng, Xiao Zhang, et al.. (2021). Comparative genomic signatures in young and old Chinese patients with colorectal cancer. Cancer Medicine. 10(13). 4375–4386. 4 indexed citations

12.

Xu, Yuzi, Yiming Lv, Fei Wu, et al.. (2020). Identification of Four Pathological Stage‐Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International. 2020(1). 2137319–2137319. 11 indexed citations

13.

Bai, Bingjun, Lina Shan, Jianhong Wang, et al.. (2020). Small molecule 2,3‑DCPE induces S phase arrest by activating the ATM/ATR‑Chk1‑Cdc25A signaling pathway in DLD‑1 colon cancer cells. Oncology Letters. 20(6). 1–1. 9 indexed citations

14.

Xie, Binbin, Bingjun Bai, Yuzi Xu, et al.. (2019). Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer. Signal Transduction and Targeted Therapy. 4(1). 51–51. 30 indexed citations

15.

Shan, Lina, Yiming Lv, Bingjun Bai, Xuefeng Huang, & Hongbo Zhu. (2018). Variability in HER2 expression between primary colorectal cancer and corresponding metastases. Journal of Cancer Research and Clinical Oncology. 144(11). 2275–2281. 24 indexed citations

16.

Bai, Bingjun, et al.. (2018). Lobaplatin suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model. Biomedicine & Pharmacotherapy. 108. 486–491. 8 indexed citations

17.

Bai, Bingjun, et al.. (2018). Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer. International Journal of Oncology. 52(4). 1129–1138. 4 indexed citations

18.

Xie, Binbin, Rongjie Zhao, Bingjun Bai, et al.. (2018). Identification of key tumorigenesis‑related genes and their microRNAs in colon cancer. Oncology Reports. 40(6). 3551–3560. 27 indexed citations

19.

Bai, Bingjun, Lina Shan, Binbin Xie, et al.. (2017). Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer. Oncology Letters. 15(3). 3161–3166. 18 indexed citations

20.

Chen, Engeng, Zhiru Zeng, Bingjun Bai, Jing Zhu, & Zhangfa Song. (2016). The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis. Oncotarget. 7(35). 56526–56539. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact